International Symposium on Microbes and Cancer Research
Set for March 2-3, the upcoming conference promises to bring together globally recognized experts from various fields related to cancer science.
The event, hosted by Tampa General Hospital (TGH) Cancer Institute and the USF Health Morsani College of Medicine, will highlight critical intersections between microbes, genetics, and cancer treatment. The 'Microbes, Genes & Cancer' Symposium aims to unpack how various biological factors contribute to cancer development and treatment responsiveness.
In celebration of the TGH Cancer Institute's Fifth Anniversary, the symposium is poised to gather distinguished basic scientists, clinical practitioners, and an influential panel of translational researchers. These experts have made groundbreaking contributions to areas such as cancer immunology and biology. Their collective insights will provide attendees with the latest advancements in diagnosing and treating cancers linked to microbial influences.
This conference comes at a crucial time for cancer research, with evidence increasingly pointing to the roles of viral, bacterial, and immune system interactions in influencing cancer risks and responses to treatments. Participants will explore diverse topics, including the relationship between viral and bacterial actions in carcinogenesis, the role of microbiomes in tumor growth, and novel therapeutic avenues leveraging immune modulation.
A significant highlight of the agenda on March 3 will be a session celebrating 50 years since Dr. Robert C. Gallo’s pivotal discovery of interleukin-2 (IL-2). This ground-breaking cytokine has paved the way for modern immunotherapy treatments. Esteemed speakers from various prestigious institutions will gather to commemorate this milestone and reflect upon ongoing advancements in immunotherapy that stem from Dr. Gallo's work.
Keynote Speakers and Special Sessions
The symposium will feature an array of renowned speakers, including:
- Robert C. Gallo, MD - USF Health Institute for Translational Virology & Innovation;
- Steve Rosenberg, MD - National Cancer Institute;
- Carl June, MD - University of Pennsylvania;
- Drew M. Pardoll, MD, PhD - Johns Hopkins University;
- Rafi Ahmed, PhD - Emory University;
- Warren Leonard, MD - National Cancer Institute.
The 'Microbes, Genes & Cancer' Symposium will precede the Global Virus Network Scientific Meeting slated for March 4-6, showcasing a synergy between virology and cancer research innovations.
Focus Areas and Target Audience
This conference is designed for a wide range of attendees, from seasoned researchers to trainees in various relevant fields. Attendees are encouraged to engage in cross-disciplinary discussions that may shape their future research and clinical practices.
The program is ideal for:
- Cancer researchers and clinician-scientists;
- Immunologists and microbiologists;
- Infectious disease experts;
- Translational researchers;
- Oncology students and fellows;
- Industry and academic leaders in cancer biology and immunotherapy.
The conference’s venue at the USF Health Morsani College of Medicine in downtown Tampa offers an accessible location for both national and international participants. Registration for the event is currently open.
About TGH Cancer Institute
The TGH Cancer Institute has a prestigious reputation among Florida’s cancer centers thanks to its alliance with the USF Health Morsani College of Medicine. Ranked among the nation’s best hospitals, TGH Cancer Institute excels in oncology care due to its state-of-the-art research, treatment, and educational programs. It is part of a recognized network offering comprehensive cancer care accredited by multiple authoritative organizations.
About Tampa General Hospital
Tampa General Hospital stands as the Tampa Bay area’s foremost academic health system, equipped with advanced facilities and services across Florida. With a bed capacity of over 1,500, TGH remains dedicated to offering inclusive healthcare services to all, regardless of financial circumstances. Its noteworthy initiatives include rapid response teams, cutting-edge technology for patient analytics, and a commitment to community health advancements.
About USF Health
USF Health is committed to pioneering the future of healthcare through a dynamic partnership of diverse health education disciplines. The institution significantly impacts the local economy while striving to tackle global health challenges. Its continued investment in research and innovation cements its status as a leader in comprehensive health solutions.
Frequently Asked Questions
What is the purpose of the 'Microbes, Genes & Cancer' Symposium?
The symposium aims to explore the relationships between microbes, genetics, and cancer, focusing on advancements in diagnosis and treatment.
Who should attend the conference?
Cancer researchers, clinician-scientists, microbiologists, and oncology trainees, among others, are encouraged to attend.
Where will the conference be held?
The event will take place at the USF Health Morsani College of Medicine in downtown Tampa.
What notable speakers will present at the event?
Renowned experts include Dr. Robert C. Gallo and several leaders from major cancer research institutions.
How can I register for the conference?
Registration is open through the official conference page, which provides necessary information for attendees.
